Infant Formula Recalled in Wake of Botulism Outbreak

November 13, 2025

The Centers for Disease Control and Prevention (CDC) and public health officials in several states, including at the Minnesota Department of Health (MDH), are investigating a multistate outbreak of infant botulism linked to ByHeart Whole Nutrition infant formula. 

As of November 8, 13 infants with suspected or confirmed infant botulism have been reported in 10 states. One case was reported in Minnesota in August. No deaths have been reported. Infants ranged in age from 16 days to approximately 6 months. 

On November 8, ByHeart Inc. recalled two lots of Whole Nutrition Infant Formula: 

  • Lot: 206VABP/251261P2 (“Use by 01 Dec 2026”) 

  • Lot: 206VABP/251131P2 (“Use by 01 Dec 2026”) 

ByHeart Whole Nutrition Infant Formula is available for sale online and at major retailers nationwide. Additional lots may be recalled as the investigation continues. Parents should not use recalled infant formula and throw it away or return it to where it was purchased. If an infant has consumed ByHeart Whole Nutrition Infant Formula and has any of these symptoms, parents should reach out to their health care provider immediately: 

  • Poor feeding 

  • Loss of head control 

  • Difficulty swallowing 

  • Decreased facial expression 

ByHeart Whole Nutrition Infant Formula makes up less than 1% of all infant formula sales in the United States, and this outbreak does not create shortage concerns of infant formula for parents and caregivers. 

Additional information about this outbreak can be found on the CDC’s website: Infant Botulism Outbreak Linked to Infant Formula, November 2025

Additional information about botulism can be found on the MDH website: Botulism (Clostridium botulinum toxin)

Latest News

Legislative Session Starts; MMA to Focus on 5 Major Issues

February 19, 2026

State lawmakers returned to St. Paul on February 17 for the second half of the 2025-2026 biennium. 

MMA Leaders Testify on Medicaid Cuts

February 19, 2026

On the second day of the legislative session, MMA leadership was already advocating for one of its top priorities - minimizing the harm of federal changes to Medical Assistance (MA). 

MMA Priority Bill on AI and Prior Auth Already Moving at the Capitol

February 19, 2026

Legislation to prohibit the use of artificial intelligence (AI) in prior authorization requirements was heard in the House Commerce Finance and Policy Committee on February 19.